![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/28/2905665/0/en/SNIPR-Biome-receives-funding-for-the-development-of-CRISPR-medicines-to-improve-Environmental-Enteric-Dysfunction-EED-in-pregnant-women.html
https://www.globenewswire.com/news-release/2024/04/22/2866554/0/en/SNIPR-Biome-receives-funding-from-CARB-X-to-support-advancement-of-CRISPR-medicine-SNIPR001-into-clinical-trials-in-haematological-cancer-patients.html
https://www.prnewswire.com/news-releases/snipr-biome-reports-positive-clinical-interim-results-for-groundbreaking-first-in-human-crispr-based-microbial-gene-therapy-301838233.html
https://www.fiercebiotech.com/biotech/small-biotech-turns-crispr-against-bacteria-reducing-e-coli-small-early-study
https://www.prnewswire.com/news-releases/snipr-biomes-data-on-first-clinical-drug-candidate-to-prevent-infections-in-hematological-cancer-patients-published-in-nature-biotechnology-301816309.html
https://www.prnewswire.com/news-releases/snipr-biome-further-strengthens-crisprcas-ip-portfolio-with-patent-grant-301708999.html
https://www.globenewswire.com/news-release/2022/08/02/2490003/0/en/SNIPR-Biome-Granted-New-US-Patent-Covering-Lytic-CRISPR-Phage.html
https://www.prnewswire.com/news-releases/snipr-biome-initiates-first-in-human-clinical-trial-with-snipr001-301528709.html
https://www.prnewswire.com/news-releases/snipr-biome-announces-opening-of-new-bsl2gmo2-classified-laboratory-in-copenhagen-denmark-301497441.html
https://www.prnewswire.com/news-releases/snipr-biome-announces-us-food-and-drug-administration-grants-fast-track-designation-for-snipr001-for-prevention-of-bloodstream-infections-in-hematologic-cancer-patients-301467663.html